Table 1.
The patient’s clinical laboratory data.
| Blood test | Result |
|---|---|
| Leucocytes (/μl) | 15,200 (nv: 5200–12400) |
| Erythrocytes (/μl) | 7.39 × 105 (nv: 4.2–5.2) |
| Hemoglobin (g/dl) | 18.5 (nv: 10–14) |
| Hematocrit (%) | 55.4 (nv: 32–42) |
| Platelet (/μl) | 84.3 × 104 (nv: 13–40) |
| MCV (fl) | 75.0 (nv: 83–100) |
| Prothrombin time (sec) | 14.8 (nv: 11–13) |
| Activated partial thromboplastin time (sec) | 31.7 (nv: 26.1–35.6) |
| D-dimer (μg/mL) | 0.53 (nv: 0–0.4) |
| Albumin (g/dl) | 4.0 (nv: 4.0–5.2) |
| Aspartate transaminase (U/I) | 21 (nv: <50) |
| Alanine transaminase (U/I) | 28 (nv: <50) |
| Lactate dehydrogenase (IU/L) | 348 (nv: 135–460) |
| Triglycerides (mg/dl) | 161 (nv: <150) |
| Low density lipoproteins (mg/dl) | 91 (nv: <130) |
| High density lipoproteins (mg/dl) | 35 (nv: >45) |
| Glucose (mg/dl) | 90 (nv: 60–100) |
| Uric acid (mg/dl) | 6.9 (nv: 3.5–7.0) |
| Blood urea nitrogen (mg/dl) | 20.8 (nv: 10–50) |
| Creatinine (mg/dl) | 0.92 (nv: 0.8–1.4) |
| eGFR (ml/min/1.7 m2) | 49 (nv: >90) |
| Creatinine kinase (IU/L) | 49 (nv: 0–173) |
| CKMB (IU/L) | 13 (nv: 7–25) |
| Sodium (mmol/l) | 142 (nv: 136–146) |
| Potassium (mmol/l) | 4.6 (nv: 3.5–5.1) |
| Chloride (mmol/l) | 106 (nv: 98–108) |
| Iron (μg/dl) | 35 (nv: 50–170) |
| Ferritin (ng/ml) | 9.8 (nv: 5–152) |
| Total iron binding capacity (μg/dl) | 342 (nv: 246–410) |
| Troponin-I (pg/ml) | 13 (nv: <26.2) |
| Thyroxine (ng/ml) | 0.87 (nv: 0.7–1.5) |
| Thyroid stimulating hormone (μU/ml) | 5.6 (nv: 0.4–4.9) |
| Erythropoietin (mU/ml) | 1.0 (nv: 4.2–23.7) |
| Neutrophil alkaline phosphatase score | 360 |
| Glycosylated hemoglobin (%) | 5.9 (nv: 4.9–6.0) |
MCV, mean corpuscular volume; eGFR, estimated glomerular filtration rate; CKMB, creatine kinase myocardial band; nv, normal value.